X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (163) 163
male (132) 132
female (131) 131
middle aged (124) 124
aged (116) 116
risk factors (101) 101
medicine, general & internal (75) 75
adult (61) 61
mortality (48) 48
abridged index medicus (47) 47
risk (45) 45
stroke (42) 42
cardiovascular disease (41) 41
hypertension (40) 40
epidemiology (39) 39
prevalence (39) 39
cardiovascular diseases (37) 37
prevention (37) 37
cardiac & cardiovascular systems (35) 35
prospective studies (32) 32
research (31) 31
risk-factors (30) 30
chile (29) 29
analysis (28) 28
health aspects (28) 28
myocardial infarction (28) 28
treatment outcome (28) 28
clinical medicine (27) 27
diabetes (27) 27
atrial fibrillation (25) 25
gastroenterology & hepatology (24) 24
health risk assessment (24) 24
klinisk medicin (24) 24
blood pressure (23) 23
studies (23) 23
aged, 80 and over (21) 21
cardiovascular diseases - epidemiology (21) 21
cardiovascular diseases - prevention & control (21) 21
case-control studies (21) 21
management (20) 20
population (20) 20
cancer (19) 19
disease (19) 19
public, environmental & occupational health (19) 19
stroke - prevention & control (19) 19
usage (19) 19
association (18) 18
cardiovascular (18) 18
colorectal cancer (18) 18
gastroenterology and hepatology (18) 18
medical research (18) 18
myocardial-infarction (18) 18
obesity (18) 18
anticoagulants (17) 17
cardiovascular diseases - mortality (17) 17
care and treatment (17) 17
cross-sectional studies (17) 17
developing countries (17) 17
drug therapy (17) 17
follow-up studies (17) 17
heart diseases (17) 17
odds ratio (17) 17
warfarin (17) 17
blood-pressure (16) 16
chile - epidemiology (16) 16
clinical trials (16) 16
diabetes mellitus (16) 16
double-blind method (16) 16
kardiologi (16) 16
socioeconomic factors (16) 16
cardiac and cardiovascular systems (15) 15
cohort studies (15) 15
colonoscopy (15) 15
medicin och hälsovetenskap (15) 15
adults (14) 14
coronary artery disease (14) 14
diagnosis (14) 14
medical and health sciences (14) 14
sex factors (14) 14
age factors (13) 13
apixaban (13) 13
cerebral infarction (13) 13
genetic aspects (13) 13
genotype (13) 13
global burden (13) 13
global health (13) 13
health (13) 13
hemorrhage (13) 13
incidence (13) 13
income (13) 13
internal medicine (13) 13
medicine (13) 13
metaanalysis (13) 13
risk assessment (13) 13
therapy (13) 13
aspirin (12) 12
atrial fibrillation - complications (12) 12
atrial fibrillation - drug therapy (12) 12
cardiovascular diseases - etiology (12) 12
cholesterol (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 09/2013, Volume 310, Issue 9, pp. 959 - 968
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10046, pp. 761 - 775
Summary Background Stroke is a leading cause of death and disability, especially in low-income and middle-income countries. We sought to quantify the... 
Internal Medicine | ETHNIC-DIFFERENCES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CARDIOVASCULAR-DISEASE | ALCOHOL-CONSUMPTION | DIETARY PATTERNS | ISCHEMIC-STROKE | BURDEN | HEMORRHAGIC STROKE | BLOOD-PRESSURE | ATRIAL-FIBRILLATION | Humans | Middle Aged | Male | Apolipoproteins B - blood | Motor Activity | Cerebral Hemorrhage - blood | Hypertension - blood | Stroke - pathology | Brain Ischemia - blood | Obesity, Abdominal - epidemiology | Odds Ratio | Waist-Hip Ratio | Brain Ischemia - complications | Brain Ischemia - epidemiology | Risk Factors | Self Report | Atrial Fibrillation - complications | International Cooperation | Biomarkers - blood | Evidence-Based Medicine | Health Behavior | Stroke - etiology | Obesity, Abdominal - complications | Cerebral Hemorrhage - complications | Smoking - adverse effects | Africa - epidemiology | Case-Control Studies | Diabetes Complications - epidemiology | Adult | Female | Stroke - epidemiology | Hypertension - epidemiology | Diabetes Complications - prevention & control | Stroke - prevention & control | Risk Reduction Behavior | Europe - epidemiology | Feeding Behavior | China - epidemiology | Alcohol Drinking - adverse effects | Australia - epidemiology | Stroke - blood | Middle East - epidemiology | Asia - epidemiology | Atrial Fibrillation - epidemiology | Cerebral Hemorrhage - epidemiology | Alcohol Drinking - epidemiology | Smoking - epidemiology | Hypertension - complications | Aged | Apolipoprotein A-I - blood | Stroke (Disease) | Risk factors | Studies | Pathology | Stroke | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 24, pp. 2359 - 2368
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 7, pp. 612 - 623
Journal Article